Clinical Trial Detail

NCT ID NCT02015208
Title Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre|Novartis
Indications

chronic lymphocytic leukemia

Therapies

Ruxolitinib

Age Groups: senior

No variant requirements are available.